TAK — TAKEDA PHARMACEUTICAL CO LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 392 SEC-registered investment managers reported holding TAK (TAKEDA PHARMACEUTICAL CO LTD) in their latest 13F filings, with a combined reported value of $2.17B across 132.70M shares. That is +3.8% by share count (+4.55M shares) versus the previous quarter, while reported value moved -9.8%. Ownership is concentrated: the five largest holders account for 45.3% of reported value and the top ten for 61.7%.
Compared with the prior quarter, 66 opened new positions, 152 added to existing stakes, 99 trimmed, 49 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of TAKEDA PHARMACEUTICAL CO LTD (TAK) include Capital Research Global Investors, Capital Research Global Investors, GROUPAMA ASSET MANAGMENT, ranked by reported 13F value among the 690 institutional holders on this page.
TAK is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding TAK
The superinvestors we track who report TAK in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 45.31K | $824.19K | 0.00% | Add |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 334 | 86.12M | $1.57B | +12.9% |
| Q2 2026 | 392 | 132.70M | $2.17B | +3.8% |
| Q1 2026 | 374 | 122.71M | $2.31B | +13.3% |
| Q4 2025 | 359 | 105.06M | $1.67B | +4.7% |
| Q3 2025 | 336 | 101.00M | $1.49B | +3.1% |
| Q2 2025 | 317 | 96.27M | $1.50B | +15.7% |
| Q1 2025 | 311 | 84.50M | $1.26B | -5.7% |
| Q4 2024 | 293 | 87.15M | $1.15B | -3.9% |
Over the 8 quarters shown, institutional share counts decreased 1% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+15.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 26.95M | $490.27M | 0.07% | Add | |
| 10.97M | $199.62M | 0.01% | Add | |
| 8.23M | $149.78M | 0.01% | Add | |
| 3.94M | $71.65M | 0.00% | Add | |
| 2.99M | $54.45M | 0.02% | Reduce | |
| 2.29M | $41.70M | 0.06% | Reduce | |
| 2.15M | $39.20M | 0.08% | Reduce | |
| 1.96M | $36.29M | 0.00% | Add | |
| 1.81M | $32.98M | 3.79% | Reduce | |
| 1.80M | $32.81M | 0.02% | Reduce | |
| 1.61M | $29.34M | 0.04% | Add | |
| 1.54M | $27.99M | 0.02% | Reduce | |
| 1.41M | $25.60M | 25.05% | New | |
| 1.08M | $19.60M | 0.03% | Add | |
| 761.69K | $13.86M | 0.18% | Reduce | |
| 708.29K | $12.88M | 0.01% | Add | |
| 692.78K | $12.60M | 0.01% | Reduce | |
| 616.15K | $11.21M | 0.01% | Add | |
| 567.53K | $10.32M | 0.01% | Reduce | |
| 564.47K | $10.27M | 1.02% | New | |
| 444.99K | $8.09M | 0.09% | Add | |
| 436.51K | $7.94M | 0.09% | Add | |
| 435.24K | $7.92M | 0.01% | Add | |
| 361.67K | $6.58M | 0.00% | Reduce | |
| 355.99K | $6.47M | 0.01% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.30M | $309.34M | 0.04% | Add | |
| 19.30M | $309.34M | 0.04% | Add | |
| 9.60M | $153.88M | 0.01% | Add | |
| 6.99M | $112.13M | 0.01% | Add | |
| 6.05M | $96.99M | 0.14% | Reduce | |
| 5.13M | $82.15M | 0.02% | Reduce | |
| 2.52M | $79.74M | 0.23% | Add | |
| 4.54M | $72.77M | 0.51% | Add | |
| 3.73M | $59.84M | 0.03% | Add | |
| 3.69M | $59.12M | 0.00% | Add | |
| 2.57M | $41.17M | 0.06% | Reduce | |
| 2.21M | $35.39M | 0.07% | New | |
| 2.11M | $33.90M | 0.02% | Add | |
| 2.05M | $32.85M | 0.02% | Reduce | |
| 2.05M | $32.85M | 0.05% | Reduce | |
| 1.82M | $29.24M | 3.34% | Add | |
| 1.74M | $27.90M | 0.00% | Reduce | |
| 1.67M | $26.83M | 0.02% | Reduce | |
| 1.60M | $25.62M | 0.01% | Add | |
| 1.53M | $24.46M | 0.01% | Add | |
| 1.53M | $24.46M | 0.01% | Add | |
| 1.40M | $22.48M | 0.03% | Add | |
| 1.15M | $18.45M | 0.01% | Add | |
| 1.05M | $16.84M | 0.01% | New | |
| 1.05M | $16.84M | 0.02% | New |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.10M | $353.81M | 0.06% | Add | |
| 19.10M | $353.81M | 0.06% | Add | |
| 7.12M | $131.82M | 0.01% | Add | |
| 6.47M | $119.82M | 0.01% | Add | |
| 6.42M | $118.99M | 0.18% | New | |
| 5.62M | $104.06M | 0.04% | Add | |
| 4.43M | $82.06M | 0.58% | Add | |
| 2.10M | $74.92M | 0.23% | Add | |
| 3.18M | $58.83M | 0.00% | Add | |
| 3.12M | $57.71M | 0.03% | Reduce | |
| 2.99M | $55.36M | 0.09% | Add | |
| 2.74M | $50.75M | 0.02% | Reduce | |
| 2.60M | $48.20M | 0.03% | Reduce | |
| 2.60M | $48.20M | 0.09% | Reduce | |
| 2.26M | $41.86M | 0.03% | Reduce | |
| 1.97M | $36.50M | 0.03% | Reduce | |
| 1.96M | $36.32M | 0.01% | Add | |
| 1.80M | $33.31M | 3.99% | Add | |
| 1.41M | $26.15M | 0.01% | Add | |
| 1.29M | $23.88M | 0.05% | Add | |
| 1.14M | $21.04M | 0.01% | Add | |
| 894.42K | $16.56M | 0.01% | Add | |
| 894.42K | $16.56M | 0.01% | Add | |
| 886.84K | $16.42M | 0.09% | New | |
| 777.15K | $14.39M | 0.21% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.49M | $210.26M | 0.04% | Add | |
| 13.49M | $210.26M | 0.04% | Add | |
| 6.37M | $99.36M | 0.01% | Reduce | |
| 5.68M | $88.60M | 0.05% | Add | |
| 4.81M | $74.91M | 0.03% | Reduce | |
| 4.29M | $66.94M | 0.04% | Add | |
| 4.29M | $66.94M | 0.13% | Add | |
| 4.12M | $64.29M | 0.04% | Reduce | |
| 4.06M | $63.25M | 0.00% | Reduce | |
| 3.88M | $60.52M | 0.46% | Reduce | |
| 1.91M | $58.95M | 0.19% | Add | |
| 2.73M | $42.59M | 0.00% | Reduce | |
| 2.62M | $40.82M | 0.06% | Reduce | |
| 2.38M | $37.15M | 0.03% | Reduce | |
| 2.31M | $35.94M | 0.03% | Add | |
| 1.70M | $26.49M | 0.00% | Reduce | |
| 1.50M | $23.32M | 2.82% | Add | |
| 1.36M | $21.27M | 0.01% | Reduce | |
| 1.07M | $16.67M | 0.04% | Add | |
| 1.06M | $16.53M | 0.01% | Add | |
| 1.02M | $15.91M | 0.01% | Add | |
| 962.50K | $15.01M | 0.05% | Add | |
| 823.20K | $12.83M | 0.05% | Reduce | |
| 745.18K | $11.62M | 0.17% | Add | |
| 679.28K | $10.59M | 0.01% | Reduce |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.40M | $196.24M | 0.04% | Add | |
| 13.40M | $196.24M | 0.04% | Add | |
| 7.69M | $112.59M | 0.01% | Add | |
| 5.89M | $86.29M | 0.05% | Add | |
| 4.95M | $72.52M | 0.03% | Add | |
| 4.19M | $61.30M | 0.00% | Add | |
| 3.93M | $57.56M | 0.46% | Add | |
| 3.86M | $56.58M | 0.07% | Add | |
| 3.31M | $48.42M | 0.00% | Reduce | |
| 3.00M | $43.98M | 0.20% | New | |
| 2.83M | $41.41M | 0.03% | Add | |
| 2.67M | $39.05M | 0.02% | Reduce | |
| 2.52M | $36.86M | 0.03% | Reduce | |
| 1.82M | $26.70M | 0.00% | Reduce | |
| 1.78M | $26.00M | 0.06% | Add | |
| 817.98K | $23.87M | 0.07% | Add | |
| 1.49M | $21.76M | 2.69% | Hold | |
| 1.16M | $17.02M | 0.02% | Reduce | |
| 1.03M | $15.14M | 0.01% | Add | |
| 973.86K | $14.26M | 0.04% | Add | |
| 866.61K | $12.69M | 0.00% | Reduce | |
| 766.28K | $11.22M | 0.01% | Add | |
| 766.28K | $11.22M | 0.01% | Add | |
| 727.23K | $10.65M | 0.16% | Hold | |
| 571.86K | $8.37M | 0.82% | New |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 13.30M | $205.55M | 0.04% | Add | |
| 13.30M | $205.55M | 0.04% | Add | |
| 7.62M | $117.80M | 0.01% | Add | |
| 4.50M | $69.58M | 0.03% | Reduce | |
| 4.10M | $63.41M | 0.00% | Add | |
| 4.02M | $62.22M | 0.04% | Add | |
| 3.71M | $57.39M | 0.52% | Add | |
| 3.55M | $54.90M | 0.00% | Add | |
| 3.30M | $51.01M | 0.07% | Add | |
| 3.09M | $47.75M | 0.08% | Add | |
| 3.09M | $47.75M | 0.02% | Add | |
| 2.60M | $40.22M | 0.03% | Reduce | |
| 2.53M | $39.17M | 0.07% | Reduce | |
| 2.03M | $31.38M | 0.00% | Add | |
| 798.55K | $24.54M | 0.07% | Add | |
| 1.49M | $23.02M | 2.99% | Add | |
| 1.33M | $20.58M | 0.02% | Reduce | |
| 1.22M | $18.84M | 0.01% | Reduce | |
| 1.04M | $16.03M | 0.00% | Add | |
| 1.01M | $15.66M | 0.01% | Add | |
| 879.87K | $13.60M | 0.00% | Reduce | |
| 850.90K | $13.15M | 0.03% | Add | |
| 797.04K | $12.32M | 0.07% | Add | |
| 727.19K | $11.24M | 0.18% | Add | |
| 534.03K | $8.26M | 0.02% | Reduce |
New Positions (Q2 2026)
- Qube Research & Technologies Ltd 2.21M sh · $35.39M
- Millennium Management 1.05M sh · $16.84M
- MILLENNIUM MANAGEMENT LLC 1.05M sh · $16.84M
- JANE STREET GROUP, LLC 769.00K sh · $12.33M
- Sixth Street Partners Management Company, L.P. 619.02K sh · $9.92M
- PFM Health Sciences, LP 444.17K sh · $7.12M
- Hudson Bay Capital Management LP 275.00K sh · $4.41M
- Nuveen, LLC 174.36K sh · $2.79M
- TUDOR INVESTMENT CORP ET AL 100.15K sh · $1.61M
- Dorsey Wright & Associates 94.28K sh · $1.51M
- Point72 Asset Management 77.66K sh · $1.24M
- Graham Capital Management, L.P. 75.65K sh · $1.21M
Fully Exited (vs previous quarter)
- Capital Wealth Planning, LLC sold 886.84K sh · $16.42M
- Trexquant Investment LP sold 229.46K sh · $4.25M
- Brooklyn Investment Group sold 174.90K sh · $3.24M
- Aquatic Capital Management LLC sold 153.76K sh · $2.85M
- XTX Topco Ltd sold 71.32K sh · $1.32M
- First Affirmative Financial Network sold 56.10K sh · $1.04M
- Squarepoint Ops LLC sold 54.39K sh · $1.01M
- YOUSIF CAPITAL MANAGEMENT, LLC sold 32.39K sh · $599.94K
- Lester Murray Antman dba SimplyRich sold 30.70K sh · $568.00K
- Private Advisor Group, LLC sold 26.49K sh · $490.54K
- Bridgefront Capital, LLC sold 26.41K sh · $489.04K
- DGS Capital Management, LLC sold 23.11K sh · $427.92K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors | 26.95M | 19.30M | 19.10M | 13.49M | 13.40M | 13.30M | 13.20M | 13.16M | 13.14M | 13.13M | 13.12M | 14.30M | 13.79M | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 10.97M | 9.60M | 7.12M | 4.06M | 4.19M | 4.10M | 3.87M | 3.39M | 2.91M | 2.62M | 2.57M | 2.18M | 2.59M | 2.48M | 2.49M | 2.30M | 2.01M | 1.85M | 2.45M | 1.92M |
| Morgan Stanley | 8.23M | 6.99M | 6.47M | 6.37M | 7.69M | 7.62M | 5.70M | 5.60M | 5.35M | 4.99M | 5.00M | 4.85M | 5.23M | 4.78M | 4.58M | 4.52M | 4.62M | 4.24M | 323.18K | 700.61K |
| BlackRock Inc | 3.94M | 3.69M | 3.18M | 2.73M | 3.31M | 3.55M | 2.63M | 2.20M | 1.89M | — | — | — | — | — | — | — | — | — | — | — |
| Arrowstreet Capital | 2.99M | 3.73M | 3.12M | 5.68M | 2.83M | 1.22M | 1.40M | 4.22M | 4.64M | 2.32M | 1.36M | 1.91M | 2.47M | 2.33M | 1.06M | 3.90M | 1.44M | 1.03M | 161.71K | — |
| Renaissance Technologies | 2.29M | 2.57M | 2.99M | 2.62M | 3.86M | 3.30M | 3.16M | 3.08M | 3.22M | 2.95M | 3.12M | 3.33M | 3.23M | 3.65M | 2.97M | 2.86M | 2.85M | 2.83M | 1.99M | 1.72M |
| Qube Research & Technologies Ltd | 2.15M | 2.21M | — | 197.51K | 1.78M | 349.66K | 293.70K | 179.94K | 130.12K | — | 114.21K | 433.52K | 286.70K | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1.96M | 744.92K | 453.98K | 242.18K | 247.53K | 179.76K | 279.42K | 83.83K | 43.10K | 57.70K | 73.35K | 73.08K | 292.13K | 307.53K | 74.11K | 16.94K | 17.94K | 17.05K | 17.33K | 17.43K |
| MANAGED ASSET PORTFOLIOS, LLC | 1.81M | 1.82M | 1.80M | 1.50M | 1.49M | 1.49M | 1.47M | 1.42M | 1.62M | 1.61M | 1.68M | 1.76M | 1.74M | — | — | — | — | — | — | — |
| FIRST TRUST ADVISORS LP | 1.80M | 2.11M | 1.97M | 2.38M | 2.52M | 2.60M | 2.76M | 3.24M | 3.18M | — | — | — | 233.12K | — | — | — | — | — | — | — |
| Quantinno Capital Management LP | 1.61M | 1.40M | 1.29M | 1.07M | 973.86K | 797.04K | 516.04K | 481.83K | 361.71K | 351.45K | 247.07K | 142.52K | 145.37K | — | — | — | — | — | — | — |
| VAN ECK ASSOCIATES CORP | 1.54M | 1.67M | 2.26M | 2.31M | 1.16M | 1.33M | 2.17M | 2.21M | 2.18M | 2.04M | 1.68M | 1.32M | 1.28M | — | — | — | — | — | — | — |
| XY Capital Ltd | 1.41M | — | — | — | 200.03K | — | 95.83K | 162.70K | 164.49K | 344.05K | 222.28K | 765.14K | 143.70K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 1.08M | 714.14K | 190.41K | 185.55K | 11.19K | 11.85K | 676 | 500.68K | 3.22K | 624 | 712 | 712 | 795 | — | — | — | — | — | — | — |
| Crossmark Global Holdings, Inc. | 761.69K | 783.84K | 777.15K | 745.18K | 727.23K | 727.19K | 396.83K | 210.48K | 54.69K | 34.63K | 34.15K | 35.66K | 36.28K | — | — | — | — | — | — | — |
| Creative Planning | 708.29K | 584.78K | 543.00K | 395.39K | 463.39K | 372.06K | 299.56K | 251.34K | 157.63K | 107.76K | 145.13K | 106.12K | 124.99K | — | — | — | — | — | — | — |
| STIFEL FINANCIAL CORP | 692.78K | 722.86K | 628.55K | 554.29K | 508.92K | 454.02K | 401.78K | 435.14K | 440.67K | 216.07K | 294.21K | 208.44K | 293.81K | — | — | — | — | — | — | — |
| AMERICAN CENTURY COMPANIES INC | 616.15K | 584.56K | 515.36K | 408.60K | 398.97K | 357.03K | 316.21K | 301.09K | 283.98K | 262.99K | 245.63K | 227.02K | 211.93K | — | — | — | — | — | — | — |
| Focus Partners Wealth | 567.53K | 679.95K | 482.39K | 562.05K | 100.59K | 89.78K | 82.74K | 79.64K | 14.95K | 127.81K | 62.82K | — | — | — | — | — | — | — | — | — |
| ABC ARBITRAGE SA | 564.47K | — | — | — | 571.86K | — | 335.86K | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold TAK?
As of 2026-Q2, 392 institutional funds reported holding TAK (TAKEDA PHARMACEUTICAL CO LTD) in SEC 13F filings, with a combined reported value of $2.17B.
How many shares of TAK do institutions own?
13F filers reported 132.70M shares of TAK, worth $2.17B in aggregate at the end of 2026-Q2.
Is institutional ownership of TAK rising or falling?
Share counts moved +3.8% versus the prior quarter — accumulation.
Who are the top institutional holders of TAK?
The largest 13F holders are Capital Research Global Investors, Capital Research Global Investors, GROUPAMA ASSET MANAGMENT, Fidelity Management & Research (FMR), Morgan Stanley; the top 25 are ranked at the top of this page.
Who are the major shareholders of TAKEDA PHARMACEUTICAL CO LTD?
The major shareholders of TAKEDA PHARMACEUTICAL CO LTD (TAK) by reported 13F value are Capital Research Global Investors, Capital Research Global Investors, GROUPAMA ASSET MANAGMENT, Fidelity Management & Research (FMR), Morgan Stanley, among 690 institutional holders.
Which legendary investors own TAK?
1 of the legendary investors tracked on HoldingsHub report TAK (TAKEDA PHARMACEUTICAL CO LTD) in their latest 13F filings, led by Richard Pzena. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on TAK?
1 tracked superinvestors hold TAK simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.